The Valley Desk

NCT01843374 · Interventional trial

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

Overall registry status Active not recruiting

Phase 2

Conditions Unresectable Pleural or Peritoneal Malignant Mesothelioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov